Weight regain timeline after stopping Ozempic: appetite usually starts to return in the first 1 to 2 weeks as the drug clears, the scale moves fastest in months 2 to 6, and by 12 months people have regained about two-thirds of what they lost. In the STEP-1 extension trial, people regained 11.6 percentage points of a 17.3% loss within a year of stopping.
- In the STEP-1 trial, semaglutide 2.4 mg weekly plus lifestyle support produced a mean weight loss of 14.9% over 68 weeks (Wilding et al., New England Journal of Medicine, 2021).
- In the STEP-1 extension, 327 people were followed for a further year after stopping. They had lost 17.3% at week 68 and regained 11.6 percentage points by week 120, leaving a net loss of 5.6% (Wilding et al., Diabetes, Obesity and Metabolism, 2022).
- The authors’ own summary: one year after withdrawal, participants had “regained two-thirds of their prior weight loss”.
- Semaglutide has an elimination half-life of about 1 week and stays in the circulation for about 5 weeks after the last dose (FDA Ozempic prescribing information), so appetite returns gradually, not overnight.
- In SURMOUNT-4, people who switched from tirzepatide to placebo went from 20.9% below their starting weight to 9.9% below it over 52 weeks, giving back about half of what they had lost (Aronne et al., JAMA, 2024).
Introduction
Ozempic and the other GLP-1 medicines have changed weight loss for millions of people. They quieten appetite, they make smaller portions feel satisfying, and the weight comes off steadily for months. Then the prescription ends, or the cost becomes too much, or a supply problem interrupts treatment, and the question everyone asks is the same: what happens next, and how fast?
This post answers that question with the published trials, week by week and month by month: what drives each phase of regain, what the numbers actually were, and what a prevention plan looks like. It does not tell you whether to start, continue, or stop any medicine: that is a decision for you and the clinician who prescribed it, and if you are thinking about stopping, talk to them first.
What the Trials Actually Found
Two trials give us the clearest picture, and both point the same way.
STEP-1 and its extension: two-thirds back in a year
STEP-1 randomised 1,961 adults with overweight or obesity, without diabetes, to 68 weeks of once-weekly semaglutide 2.4 mg or placebo, alongside a lifestyle intervention. The semaglutide group lost a mean of 14.9% of their body weight, against 2.4% on placebo (Wilding et al., New England Journal of Medicine, 2021).
Then came the extension: 327 participants followed for a further year after treatment stopped. This group had lost slightly more than the full trial average, 17.3% at week 68. By week 120, one year after stopping, they had regained 11.6 percentage points, leaving a net loss of 5.6% from where they started. The placebo group regained 1.9 points and ended at a net loss of 0.1%. The authors concluded that one year after withdrawal, participants had regained two-thirds of their prior weight loss (Wilding et al., Diabetes, Obesity and Metabolism, 2022).
Two caveats matter. First, the analyses were exploratory, and the extension followed a subset, not the full trial population. Second, the lifestyle intervention stopped at week 68 at the same time as the drug, so the extension measures losing both the medicine and the structured support together, not the medicine alone. That is the most useful lesson in the whole study, and it shapes the prevention plan at the end of this post.
SURMOUNT-4: the same pattern with tirzepatide
SURMOUNT-4 tested the same question with tirzepatide. A total of 783 people entered a 36-week open-label lead-in and lost a mean of 20.9% of their body weight. Then 670 were randomised: half stayed on tirzepatide and half switched to placebo for 52 weeks. From week 36 to week 88, the placebo group gained 14.0% while the group that stayed on tirzepatide lost a further 5.5%. Over the whole 88 weeks, the placebo group ended 9.9% below their starting weight, against 25.3% below for those who stayed on treatment (Aronne et al., JAMA, 2024).
Put simply, the group that stopped went from 20.9% below their starting weight to 9.9% below it, giving back about half of what they had lost in a year. Only 16.6% of the placebo group kept at least 80% of their lead-in weight loss, against 89.5% of those who stayed on treatment. The drug was doing real work, and when it stopped, the weight came back.
The Timeline, Week by Week
Weeks 1 to 2: the drug starts to clear, appetite stirs
Semaglutide has an elimination half-life of about 1 week, and the FDA prescribing information states it stays in the circulation for about 5 weeks after the last dose. The drug does not vanish overnight: after one week, roughly half of the last dose remains, and after two weeks, roughly a quarter. Appetite usually starts to return gradually during these first weeks, and food thoughts that had gone quiet often come back first. The scale may not move much yet, because the drug is still partly present and early weight changes include water and glycogen, not just fat.
Weeks 3 to 6: hunger returns in earnest
By the third to sixth week, most of the drug has cleared, and hunger is usually back close to its old level. Portions that felt satisfying a month ago start to feel small. This is the phase people notice most, because the contrast with treatment is sharpest, and old habits return fastest: the evening snack, the second helping, the takeaway on a tired day. None of this is a failure of willpower. The medicine was suppressing appetite, and without it, appetite returns to where it was.
Months 2 to 6: the scale moves fastest
Months 2 to 6 are usually when the scale moves fastest. The STEP-1 extension found regain after withdrawal was comparatively rapid against other obesity medicine withdrawal trials, steepest in people who had lost 20% or more, and slowing towards the end of the extension phase. The regain curve is front-loaded: fast early, slower later. This is the window where a plan matters most, because the habits you build here decide how much of the loss you keep.
Months 6 to 12: regain slows, two-thirds back by 12 months
By the second half of the year, the pace of regain usually slows. Appetite has settled at its new level, weight has stabilised closer to its old range, and the body has adapted to the lower weight. At 12 months, the STEP-1 extension average was two-thirds of the loss regained, with a net loss of 5.6% remaining. That average hides a wide range: some people kept most of their loss, and some regained all of it. The trials do not tell us what happens after 12 months, because the published follow-up ends there, so whether the curve plateaus, continues, or overshoots the starting weight beyond a year is not yet known.
What Drives Each Phase
Regain is not one thing: different forces drive each phase, and knowing which one is acting helps you respond to it.
Appetite hormones return first
GLP-1 medicines work partly by slowing stomach emptying and partly by acting on appetite centres in the brain. When the drug clears, both effects fade and hunger returns. This is the main driver in weeks 1 to 6, and it is why the return of appetite feels so sudden: the medicine was holding back a normal appetite, not removing it.
Your body burns fewer calories at a lower weight
A smaller body needs less energy. Someone who has lost 15% of their body weight burns fewer calories a day than at their starting weight, even doing the same activities. This is metabolic adaptation, and it is the main driver in months 2 to 6. If you eat the same amount as before treatment, you will gain weight, because your daily burn is now lower. Work out your new number with our TDEE calculator and our calories calculator, and set your target from the new weight, not the old one.
Old habits return when support stops
In the STEP-1 extension, the lifestyle intervention stopped at the same time as the drug, which is a large part of why the regain was so fast. Structured support, regular check-ins, food tracking, and planned activity all make weight maintenance easier, and losing them at the same moment as the medicine is a double blow. The lesson is direct: keep the support going even if the medicine stops.
Muscle loss makes it harder
Some of the weight lost on any diet, including with GLP-1 medicines, is muscle. Less muscle means a lower daily burn, which makes regain easier. Keeping protein intake up and staying active, especially with resistance exercise, protects muscle during weight loss and makes maintenance easier afterwards. Our guide to losing weight without a gym covers the home-based options.
The Prevention Plan
Nothing in this post can promise you will keep the weight off: the trials show most people regain a large share of what they lost. But some people keep most of it, and the habits that separate them are the same habits that work for weight maintenance generally.
Keep the eating pattern, not just the weight
The portions, the protein at each meal, and the food choices that worked during treatment are the plan now. Do not wait for the scale to move: start the maintenance eating pattern in the first week after stopping, while appetite is still low, so it is a habit before hunger returns in full. If you hit a stall, read our guide to how to break a weight loss plateau before cutting calories further.
Keep moving every day
Daily activity is the strongest habit for weight maintenance. Walking is enough to start: our guide to whether walking burns belly fat explains why it works and how much to aim for. Add resistance exercise two or three times a week to protect muscle, even bodyweight exercise at home.
Weigh yourself weekly and act early
Weigh yourself once a week, on the same day, at the same time, and write the number down. A rise of 1 to 2 kg in the first weeks can be water and glycogen, not fat, so do not panic at a single reading. But a steady upward trend over several weeks is the signal to act: tighten portions, check your calorie target against your new weight, and review your activity. Early action is easier than late action: 2 kg is easier to reverse than 10 kg.
Keep the support
Keep whatever support helped during treatment: the clinician, the dietitian, the walking group, the friend who checks in. The STEP-1 extension shows what happens when support stops at the same time as the medicine. If cost is the reason for stopping, ask your clinician what lower-cost options exist for ongoing support. Do not buy compounded peptides or seek a GLP-1 without a prescription: unregulated products carry real risks.
Plan for a long timeline
Obesity is a long-term condition, and the STEP-1 authors concluded that ongoing treatment is required to maintain the improvements in weight and health. If you have stopped treatment, plan as if maintenance is a long-term project, not a three-month effort. The habits that keep weight off are the same habits that would have kept it off without the medicine, and they need the same long-term attention.
Frequently Asked Questions
How fast do you regain weight after stopping Ozempic?
Appetite usually starts to return in the first 1 to 2 weeks as the drug clears, and the scale moves fastest in months 2 to 6. By 12 months, people in the STEP-1 extension had regained about two-thirds of what they had lost, though the range around that average is wide.
Do you regain all the weight after stopping Ozempic?
On average, no, but it is close. In the STEP-1 extension, people regained 11.6 percentage points of a 17.3% loss, leaving a net loss of 5.6% after a year. Some kept most of their loss and some regained all of it. The trials do not follow people beyond 12 months, so longer-term outcomes are not yet published.
Why does appetite come back so quickly after stopping?
Semaglutide has a half-life of about 1 week, so the drug level halves each week after the last dose and is mostly gone within about 5 weeks. As it clears, the appetite suppression fades, and hunger returns to roughly its old level. The return feels sudden because the contrast with treatment is sharp.
Can you keep the weight off after stopping Ozempic?
Some people do. In SURMOUNT-4, 16.6% of people who switched to placebo kept at least 80% of their weight loss after a year, against 89.5% of those who stayed on treatment. Keeping the eating pattern, staying active, weighing weekly, and keeping support going are the habits that give you the best chance.
Should I stop Ozempic if I have reached my goal weight?
That is a decision for you and the clinician who prescribed it. This post does not recommend stopping or continuing any medicine. Talk to your clinician before making any change, and ask what ongoing support and monitoring look like if you do stop.
—
Sources
- Wilding JPH, Batterham RL, Calanna S, et al. New England Journal of Medicine. 2021;384(11):989-1002. STEP-1: semaglutide 2.4 mg weekly plus lifestyle intervention gave a mean weight loss of 14.9% over 68 weeks, against 2.4% on placebo, in 1,961 adults. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Wilding JPH, Batterham RL, Davies M, et al. Diabetes, Obesity and Metabolism. 2022;24(8):1553-1564. STEP-1 extension: 327 participants, 17.3% lost at week 68, 11.6 percentage points regained by week 120, net loss 5.6%; authors concluded participants regained two-thirds of their prior weight loss. https://pubmed.ncbi.nlm.nih.gov/35441470/
- Aronne LJ, Sattar N, Horn DB, et al. JAMA. 2024;331(1):38-48. SURMOUNT-4: after a 36-week tirzepatide lead-in with 20.9% mean loss, the placebo group gained 14.0% over 52 weeks while the tirzepatide group lost a further 5.5%. https://pubmed.ncbi.nlm.nih.gov/38078870/
- US Food and Drug Administration. Ozempic (semaglutide) prescribing information, revised October 2025, section 12.3. Elimination half-life of approximately 1 week; semaglutide present in the circulation for about 5 weeks after the last dose. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s035,209637s037lbl.pdf
- Weight Insider. TDEE calculator, calories calculator, does walking burn belly fat, how to break a weight loss plateau, and lose weight without gym.
Last updated: 19 November 2026
Medical Disclaimer
This article is general information only. It is not medical advice, and it is not a substitute for advice from a qualified health professional. It does not recommend starting, continuing, or stopping any medicine. If you are taking Ozempic or any GLP-1 medicine, talk to the clinician who prescribed it before making any change to your treatment. Do not buy medicines from unregulated sources or use any medicine without a prescription.